A simple, selective, accurate, and precise High-Performance Thin-Layer chromatographic (HPTLC) method has been developed and validated for analysis of the Buclizine Hydrochloride (BUC) in bulk drug and pharmaceutical formulations. HPTLC was performed on aluminium sheets precoated with silica gel G 60F254 as a stationary phase. The mobile phase chosen for development consists of chloroform: ethyl acetate in the ratio of 8:2 (v/v). Buclizine Hydrochloride (BUC) showed good linear regression analysis over the concentration ranges 100-600 ng per spot with correlation coefficients (R2) = 0.999. The developed method was validated as per ICH guidelines for precision, recovery, robustness, and specificity. The developed method can be applied for the quality control of commercial samples of Buclizine Hydrochloride (BUC) API and its different formulations.
Select your language of interest to view the total content in your interested language